Target intelligence / Profile preview

Dietary lipids, cholesterol, and bile acids in the gastrointestinal lumen

Molecular classification
Lipid, Sterol, Bile acid, Small molecule, Other
01

Overview

Dietary lipids, cholesterol, and bile acids in the gastrointestinal lumen represent the collective group of hydrophobic molecules and emulsifiers present in the gut during the digestive process (NCBI, 2023). Dietary lipids, primarily triglycerides, undergo emulsification by bile acids and enzymatic hydrolysis by pancreatic lipases to facilitate absorption into the intestinal mucosa (StatPearls, 2023). Cholesterol in the lumen originates from both dietary intake and biliary secretion, requiring incorporation into mixed micelles for transport to the enterocyte surface (PubMed, 2021). Bile acids are steroid acids synthesized from cholesterol in the liver that act as biological detergents to solubilize these fats and fat-soluble vitamins (StatPearls, 2023). Therapeutic strategies targeting these luminal components include bile acid sequestrants, which bind bile acids to prevent their reabsorption, thereby lowering systemic LDL cholesterol levels (Mayo Clinic, 2023). Additionally, lipase inhibitors like orlistat prevent the breakdown of dietary fats to reduce caloric intake for obesity management (FDA, 2023). Because this entry describes a physiological environment and multiple chemical classes rather than a single protein or receptor, it is categorized as a composite system rather than a discrete molecular target.

Other names
Intestinal lipidsLuminal bile acidsDietary fats and sterolsGastrointestinal lipid-bile acid complex
02

Mechanism of action

Bile acid sequestration to prevent enterohepatic circulation; Inhibition of gastric and pancreatic lipases to prevent triglyceride hydrolysis; Competitive displacement of cholesterol from mixed micelles.

03

Biological functions

Lipid digestionMicelle formationCholesterol homeostasisNutrient absorptionEmulsification
04

Disease associations

HypercholesterolemiaObesityHyperlipidemiaBile acid malabsorptionSteatorrhea
05

Safety considerations

Steatorrhea (fatty stools)Malabsorption of fat-soluble vitamins (A, D, E, K)Gastrointestinal distress (bloating, flatulence, constipation)Reduced absorption of co-administered oral medications
06

Interacting drugs

Colesevelam

4 more in the full profile.

07

Biomarkers

Low-density lipoprotein cholesterol (LDL-C)Fecal fat excretionTotal serum cholesterol7α-hydroxy-4-cholesten-3-one (C4)

Beyond the preview

Go deeper on Dietary lipids, cholesterol, and bile acids in the gastrointestinal lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary lipids, cholesterol, and bile acids in the gastrointestinal lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call